University of California Los Angeles
Dr. Cheng graduated from Wuhan University with a bachelor’s degree in 1984. He received his Ph.D. in molecular biology from the Albert Einstein School of Medicine in 1990. He was trained as a postdoctoral researcher by Dr. David Baltimore at Rockefeller University and the Massachusetts Institute of Technology. Dr. Cheng has been a faculty member at UCLA since 1996, engaged in multidisciplinary research in infection, immunity, cancer and metabolism. Dr. Cheng pioneered in discovering TNFR-mediated non-canonic NF-kB and TLR-mediated interferon (IFN) induction pathways, responsible for cloning of TRAF3 and TANK. Dr. Cheng also pioneered in identifying numerous antiviral IFN stimulatory genes (ISG) including CH25H and a novel IFN-mediated anti-inflammatory gene program. Dr. Cheng has published more than 200 papers in high impact journals and has won several scientific achievement awards including the Stallman Award from the American Society for Leukemia and Lymphoma. He was elected as a Fellow of the American Association for the Advancement of Science (AAAS) in 2012 and as a member of the American Academy of Microbiology in 2018. He is also responsible for establishing the Institute of Systems Medicine in the Chinese Academy of Medical Sciences.